Clinical Development
Cancer Products
Advaxis is developing multiple platform approaches to the treatment of several cancers and HIV. Included in the chart below and the list on the left are the lead products in development which represent a market potential in excess of $10 billion.
| Products | Indication | Pre-Clinical | I | II | III |
|---|---|---|---|---|---|
| Lovaxin C | Cervical |  |
|
||
| Lovaxin C | Head & Neck | |
|||
| Lovaxin B | Breast | |
|||
| Lovaxin SCCE | Ovarian | |
|||
| Lovaxin P | Prostate | |
Home